Palisade Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,100
Closed -$1.12M 446
2017
Q1
$1.12M Sell
20,100
-2,200
-10% -$113K 0.04% 312
2016
Q4
$1.06M Sell
22,300
-1,450
-6% -$81.2K 0.04% 320
2016
Q3
$1.54M Hold
23,750
0.05% 366
2016
Q2
$1.1M Sell
23,750
-1,500
-6% -$60.4K 0.04% 402
2016
Q1
$966K Buy
+25,250
New +$835K 0.03% 426
2015
Q4
Sell
-25,250
Closed -$1.04M 534
2015
Q3
$1.04M Hold
25,250
0.03% 409
2015
Q2
$1.19M Buy
25,250
+7,000
+38% +$379K 0.03% 400
2015
Q1
$1.1M Sell
18,250
-7,000
-28% -$356K 0.03% 388
2014
Q4
$1.1M Sell
25,250
-24,389
-49% -$1.08M 0.03% 365
2014
Q3
$2.23M Buy
49,639
+300
+0.6% +$16K 0.06% 328
2014
Q2
$3.65M Buy
49,339
+6,800
+16% +$536K 0.09% 293
2014
Q1
$3.52M Buy
42,539
+3,400
+9% +$299K 0.09% 283
2013
Q4
$5.41M Sell
39,139
-14,261
-27% -$1.68M 0.14% 243
2013
Q3
$5.11M Hold
53,400
0.14% 242
2013
Q2
$3.26M Buy
+53,400
New +$2.96M 0.09% 273

Other funds holding NUS

Palisade Capital Management's NUS Position: Q2 2017 in Review

Palisade Capital Management sold out of Nu Skin (NUS) in Q2 2017, closing a stake of 20,100 shares — an estimated $1.12M sold.

Palisade Capital Management first reported a position in NUS in Q2 2013 and held it in 15 quarters. The position peaked at $5.41M in Q4 2013. 266 funds tracked by Wall St. Rank hold NUS as of Q2 2017.

  • Palisade Capital Management reported no remaining Nu Skin position as of Q2 2017 after selling out during the quarter.
  • Palisade Capital Management sold 20,100 Nu Skin shares in Q2 2017, an estimated $1.12M.
  • Palisade Capital Management first reported a position in Nu Skin in Q2 2013 and held it in 15 quarters.
  • Palisade Capital Management's Nu Skin position peaked at $5.41M in Q4 2013.
  • 266 funds tracked by Wall St. Rank held Nu Skin as of Q2 2017.

Based on Palisade Capital Management's 13F filing for Q2 2017, filed 1 Aug 2017.